1 September 2023: The Australian Technical Advisory Group on Immunisation (ATAGI) has recommended people at higher risk of severe illness get an additional 2023 COVID-19 vaccine dose (booster) if eligible. Read the
latest advice from ATAGI.
Serious adverse events following immunisation (AEFI) are notifiable conditions in NSW. Healthcare providers are required to report any serious AEFI to NSW Health and the Therapeutic Goods Administration. More information is available on
Adverse events following immunisation (AEFI).
Training modules are available for clinical staff including: